Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
ConditionHip Arthroplasty, Total
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorExactech
About this trial
A Post-Market Domestic (US) and International Data Collection to Assess Exactech Hip Systems
Eligibility criteria
Qualifiers
Subjects who agree to participate in the study that have not had surgery prior to being enrolled in the study.
Skeletally mature (18 years of age or older).
The subject is willing and able to provide written informed consent for participation in the study.
Subject is to receive an Exactech Hip System THA for any approved indication for use.
Disqualifiers
Gender
Age at surgery
Height/Weight
Indication for surgery
Trial design
Treatments tested in this trial
- Exactech Hip Systems
Treatment groups
2,946 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov